Results 11 to 20 of about 63,184 (164)

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System [PDF]

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2019
Introduction Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative ...
Thilo vanEimeren, Angelo Antonini, Daniela Berg, Nico Bohnen, Roberto Ceravolo, Alexander Drzezga, Günter U. Höglinger, Makoto Higuchi, Stephane Lehericy, Simon Lewis, Oury Monchi, Peter Nestor, Matej Ondrus, Nicola Pavese, María Cecilia Peralta, Paola Piccini, José Ángel Pineda‐Pardo, Irena Rektorová, María Rodríguez‐Oroz, Axel Rominger, Klaus Seppi, A. Jon Stoessl, Alessandro Tessitore, Stephane Thobois, Valtteri Kaasinen, Gregor Wenning, Hartwig R. Siebner, Antonio P. Strafella, James B. Rowe, MDS Neuroimaging Study Group and the JPND Working Group ASAP‐SynTau   +29 more
doaj   +2 more sources

DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. [PDF]

Nat Aging, 2023
Pereira JB, Kumar A, Hall S, Palmqvist S, Stomrud E, Bali D, Parchi P, Mattsson-Carlgren N, Janelidze S, Hansson O.   +9 more
europepmc   +3 more sources

Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. [PDF]

Behav Neurol, 2021
Petsani C, Aloizou AM, Siokas V, Messinis L, Peristeri E, Bakirtzis C, Nasios G, Dardiotis E.   +7 more
europepmc   +3 more sources

Racial and geographic disparities with gastrostomy tube placement in dementia and parkinsonian disorders. [PDF]

Parkinsonism Relat Disord, 2021
Kim DS, Kunicki ZJ, Philips OW, Jones RN, Friedman JH, Kluger B, Akbar U.   +6 more
europepmc   +3 more sources

Neuronal entropy depends on the level of alertness in the parkinsonian Globus Pallidus in vivo [PDF]

Frontiers in Neurology, 2014
A new working hypothesis of Parkinson's disease proposes to focus on the central role of entropy increase in the Basal Ganglia in movement disorders. The conditions necessary for entropy increase in vivo are, however, still not fully described.
Daniela Sabrina Andres, Daniela Sabrina Andres, Daniela Sabrina Andres, Daniel eCerquetti, Marcelo eMerello, Ruedi eStoop   +5 more
doaj   +5 more sources

Imaging of Proteinopathies in the Brains of Parkinsonian Disorders. [PDF]

Cells
Higuchi M.
europepmc   +2 more sources

A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]

Neurol Clin Pract
Bruno MK, Dhall R, Duquette A, Haq IU, Honig LS, Lamotte G, Mari Z, McFarland NR, Montaser-Kouhsari L, Rodriguez-Porcel F, Shurer J, Siddiqui J, Spears CC, Wills AA, Diaz K, Golbe LI, as the Diagnosis and Treatment Working Group, CurePSP Center of Care (CoC) Network.   +17 more
europepmc   +3 more sources

Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program. [PDF]

Clin Park Relat Disord
Afshari M, Kang K, Butala AA, Guenther J, Razzak R, Katz M, Galifianakis NB, Pantelyat A.   +7 more
europepmc   +2 more sources

Biomarker bust: meta-analyses reveal unreliability of neuronal extracellular vesicles for diagnosing parkinsonian disorders. [PDF]

Neural Regen Res
Taha HB.
europepmc   +2 more sources

Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders. [PDF]

Clin Park Relat Disord
Kawazoe T, Sugaya K, Nakata Y, Okitsu M, Takahashi K.   +4 more
europepmc   +2 more sources